Entities / Company
Bio-Rad Laboratories.
American life science research firm
- Reports this week
- 0
- Active events
- 0
- Connections
- 63
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.Some support1 report1 development inside
-
Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.Some support1 report
-
Bio-Rad Laboratories filed its required 13F reports with the SEC on September 7, 2026.Some support1 report
-
Bio-Rad Laboratories and BioLife Solutions, Inc. are life science companies that develop products marketed in the Middle East, Europe, and the US.Some support1 report
-
Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.Some support1 report2 developments inside
Gone quiet
No new reports in 90+ days-
Illumina and Bio-Rad Laboratories collaborate on advanced life science technologies.Some support1 report1 development inside
-
RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.Some support4 reports
-
Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.Some support1 report
-
Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.Some support1 report
-
GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.Some support1 report
-
A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.Some support3 reports
-
Bio-Rad Laboratories is headquartered in Hercules, California.Some support3 reports
-
Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.Some support1 report
-
Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.Some support1 report
-
Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.Speculative1 report
-
Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.Some support1 report
-
Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.Some support1 report1 development inside
-
Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.Some support1 report
-
Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.Some support1 report
-
Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.Some support2 reports
-
Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.Some support1 report
-
Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.Some support1 report
-
The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bio-Rad Laboratories this week
News at the entities that move Bio-Rad Laboratories most-
Citigroup Mentioned togetherMorgan Stanley and Citigroup cut AutoNation's rating and price objective on November 6, 2026.Moves Bio-Rad Laboratories
-
National Institutes of Health TransactionalThe National Institutes of Health is funding research efforts at the University of Kentucky Center for Clinical and Translational Science.Moves Bio-Rad Laboratories
-
Royal Bank of Canada Mentioned togetherMorgan Stanley began coverage of Vylor with an 'overweight' rating, while Royal Bank of Canada authorized a $3.00 billion stock buyback plan.Moves Bio-Rad Laboratories
-
China Shared contextTrade disruptions are occurring due to tensions between Afghanistan and Pakistan, while a new route extends the China-Pakistan Economic Corridor.Moves Bio-Rad Laboratories
-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves Bio-Rad Laboratories
-
GSK OperationalBoth GSK and Galderma operate within the pharmaceutical and biotech sectors.Moves Bio-Rad Laboratories
Connections
The 11 strongest of 63, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
Bio-Rad Laboratories is required to file regulatory reports, such as 13F filings, with the SEC to operate in the market.
-
Royal Bank of Canada Mentioned together
Royal Bank of Canada provides investment ratings and price objectives for Bio-Rad Laboratories stock.
-
Illumina Operational
The companies collaborate on advanced life science technologies.
-
Charles River Laboratories Operational
Both companies are described as competitors occupying vital positions within the biotech supply chain.
-
National Institutes of Health Transactional
NIH is noted as a potential purchaser of goods and services from Bio-Rad Laboratories.
-
China Shared context
Bio-Rad Laboratories operates within the Chinese market context, where sales performance is tracked.
-
Citigroup Mentioned together
Citigroup has published research reports raising its price target for Bio-Rad Laboratories.
-
MarketBeat Mentioned together
MarketBeat reports consensus recommendations related to Bio-Rad Laboratories.
History
Events by the month they beganSeptember 2026
3 events- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
- Bio-Rad Laboratories filed its required 13F reports with the SEC on September 7, 2026.
- Bio-Rad Laboratories and BioLife Solutions, Inc. are life science companies that develop products marketed in the Middle East, Europe, and the US.
August 2026
4 events- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- RBC lifted its price objective for Bio-Rad Laboratories, and Citigroup also raised its price objective for the company.
- Bio-Rad Laboratories reported sales growth in the Americas, while the NIH noted rising funding but lagging purchasing.
- Bio-Rad Laboratories reported that its sales in China fell significantly in the high teens.
July 2026
1 eventShow 1 earlier month
June 2026
16 events- Vision 2030 is driving healthcare infrastructure investment in Saudi Arabia, fueled by the rise of chronic diseases and market growth.
- GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.
- A test highlighting value in personalized medicine is mentioned in a competitive market assessment involving Roche, Bio-Rad, and Charles River.
- Bio-Rad Laboratories is headquartered in Hercules, California.
- Phibro Animal Health's acquisition strengthens its ddPCR offering and expands into new markets.
- Trump's pledge to unleash oil and gas benefits stocks, specifically involving Bio-Rad Laboratories.
- Jim Barry joined Bio-Rad Laboratories on July 7, 2025, serving as EVP and President of the company's Life Science Group.
- Bio-Rad launched its QX Continuum digital PCR system, utilizing Nuvia wPrime 2A resin and Foresight Pro columns.
- Major diagnostic companies, including Bio-Rad, Quest Diagnostics, and Myriad Genetics, are driving market growth.
- Saudi Arabia is a key region for the HPV testing market, with growth driven by diagnostic technology advancements from companies like Qiagen and Bio-Rad.
- Mehta was appointed EVP Global Commercial Operations at Bio-Rad, while Crowley retired, and Mehta's past roles at Dow Chemical were noted.
- Bio-Rad Laboratories acquired Stilla Technologies and received $250 million from Sartorius AG shares.
- Bio-Rad Laboratories acquired Stilla Technologies and Norman Schwartz was appointed as Chairman and CEO.
- Market growth in the STD Diagnostic Market is being driven by technological advancements and increased STD prevalence.
- Bio-Rad Laboratories' stock performance was compared against the Russell 2000 Index and HFRX Equity Hedge Index in September 2025.
- The event mentions George Joseph as founder of Mercury, Alice Schwartz founding Bio-Rad, and groups Elon Musk and Mark Zuckerberg among young tech billionaires.